Home > PJ (current issue) > Leading article | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 269 No 7228 p834
14 December 2002

This article
Reprint
Photocopy

Leading Articles

Cherish The Journal

Dr John Evans, as he said goodbye to the Council of the Royal Pharmaceutical Society after serving 12 years as a Privy Council nominee member, urged his fellow Council members to cherish The Journal. Coincidentally, he made his comments the day before the Council decided that to secure the future of the Society's publications they should be established as a separate company — which would include The Pharmaceutical Journal.

Senior staff on The Journal have been fully involved in preliminary discussions about the implications of this move, which would become necessary if the Society's exploration of charitable status is successful (see p866) because business activities are incompatible with such status.

We are keenly aware that whatever new structure is put in place, it must preserve editorially what is good and beneficial for the membership and the Society. However, we also must recognise that The Journal makes a significant contribution to the Society's coffers and that we have a responsibility both to the membership and the Society to preserve that as well.

The membership should be reassured that moving The Journal and other publishing activities to a more business-friendly environment will be a benefit because it will give those managing the enterprises more freedom than they have currently.

Any change, however, will continue to acknowledge the complex relationship The Pharmaceutical Journal has with the Society and the members. Articles of association will affirm the status of the PJ as the official journal of the Society and will enshrine its role as deliverer of official notices and transactions to the membership. It will continue to be published on a weekly basis, whatever financial conditions prevail, and be sent free of charge to all members. The Society will be the sole beneficiary of any financial surplus.

Editorially, it will continue to promote the science, practice and profession of pharmacy and be a forum for the dissemination of members' views and opinions. The editor will continue to pursue whatever editorial approach he or she considers to be in the interests of the profession.

The appointment of the editor will remain subject to Council approval. The governance arrangements for The Journal and its sister publications will include representatives of the membership and nominees of the Council.

In short, the editorial relationships between The Journal, The Society and members would remain unchanged and Dr Evans should be satisfied that The Journal is being cherished.

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal